Lung Cancer Clinical Trials

Showing 2741-2760 of 4,288 trials

Mixed Reality Technique Combined With 3D Printing Navigational Template for Localizing Pulmonary Nodules

NCT04552054

This study evaluates the viability and accuracy of preoperative mixed reality technique combined with three-dimensional printing navigational template guided localizing pulmonary small nodules.

Video-assisted Thoracic SurgeryLung CancerPulmonary Nodule, Solitary+1 more

Wen-zhao ZHONG136 participantsStarted May 2018

Guangzhou, Guangdong, China

UNKNOWNPhase 1/2

Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of ASK120067 in Locally Advanced and Metastatic Non Small Cell Lung Cancer

NCT03502850

ASK120067 Tablets is a Epidermal Growth Factor Receptor (EGFR) mutation selective Tyrosine Kinase Inhibitor which can efficient suppress the EGFR T790M drug-resistant mutation tumor cell in Xenograft mouse model. This study aims at local advanced or metastatic non-small cell lung cancer patients with T790M drug-resistant mutation.

Locally Advanced or Metastatic NSCLC

Jiangsu Aosaikang Pharmaceutical Co., Ltd.507 participantsStarted Nov 2017

Beijing, Beijing Municipality, China • Beijing, Beijing Municipality, China • Tianjin, Tianjin Municipality, China

TERMINATEDPhase 1

Phase Ib/II Study of M3814 With Etoposide and Cisplatin in Small Cell Lung Cancer (SCLC) Extensive Disease (ED)

NCT03116971

M3814 is an investigational drug under evaluation for treatment of lung cancer. The purpose of the study was to assess the Safety and Efficacy of M3814 in combination with chemotherapy with SCLC ED.

Small Cell Lung Cancer

EMD Serono Research & Development Institute, Inc.2 participantsStarted May 2017

Mesa, Arizona, United States • Santa Rosa, California, United States • Santa Rosa, California, United States +77 more locations

Mixed Reality Technique Combined With 3D Printing Navigational Template for Localizing Pulmonary Nodules

Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of ASK120067 in Locally Advanced and Metastatic Non Small Cell Lung Cancer

Phase Ib/II Study of M3814 With Etoposide and Cisplatin in Small Cell Lung Cancer (SCLC) Extensive Disease (ED)

Related Searches

Prediction of Esophageal and Lung Toxicities After Radiation (Chemo) Therapy

A Study of TQ-B3139 Capsules in Subjects With MET-Altered Advanced Non-small Cell Lung Cancer

Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer

A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLC

Airway and/or Pulmonary Vessels Transplantation

Camrelizumab With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung Cancer

Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer

Analgesic Non Inferiority of the Thoracic Bi-block in Comparison With Thoracic Epidural for VATS.

Improving Care After Chemotherapy

Addition of Radiotherapy to Standard Medical Treatment for Stage IV NSCLC

High Dose Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer

Study of Radiotherapy Combined With Albumin Bound Paclitaxel and Nedaplatin for Locally Advanced NSCLC

Assessing an Oral Janus Kinase Inhibitor, AZD4205, in Combination With Osimertinib in Patients Who Have Advanced Non-small Cell Lung Cancer

Erlotinib and SBRT in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

Using Rapid Cine-MRI for Monitoring Moving and Deforming Tumors

Phase II Lung Metcore - Preoperative Metformin for Lung Cancer